QuidelOrtho (QDEL) Research & Development (2021 - 2024)
QuidelOrtho (QDEL) has disclosed Research & Development for 4 consecutive years, with $59.2 million as the latest value for Q1 2024.
- Quarterly Research & Development fell 4.98% to $59.2 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $303.2 million through Mar 2024, up 8.13% year-over-year, with the annual reading at $218.7 million for FY2024, 10.73% down from the prior year.
- Research & Development hit $59.2 million in Q1 2024 for QuidelOrtho, down from $118.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $118.8 million in Q4 2023 to a low of $22.6 million in Q3 2021.
- Historically, Research & Development has averaged $59.7 million across 4 years, with a median of $62.3 million in 2023.
- Biggest five-year swings in Research & Development: skyrocketed 176.79% in 2022 and later dropped 4.98% in 2024.
- Year by year, Research & Development stood at $23.7 million in 2021, then surged by 176.79% to $65.6 million in 2022, then soared by 81.1% to $118.8 million in 2023, then crashed by 50.17% to $59.2 million in 2024.
- Business Quant data shows Research & Development for QDEL at $59.2 million in Q1 2024, $118.8 million in Q4 2023, and $62.4 million in Q4 2023.